Delivery Order SPE2DB22D6029-SPE2DB24FU1FE
Award Date
6/7/24
Potential Completion Date
7/1/24
Potential Value
$47K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $46,826.19, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is a Delivery Order for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product, with a completion date of June 20, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation.
AmerisourceBergen Drug Corp holds a single-award Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $51,082.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product, with a completion date of July 15, 2024.
Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA)...
This federal contract award to AmerisourceBergen Drug Corp's Corporate Office Division is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product. The contract has a ceiling value of $93,652.38 and an ultimate completion date of July 30, 2024. It was awarded by the Defense Logistics Agency (DLA), a defense agency, on July 9, 2024.
AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $94,112.92, is for the delivery of ULTOMIRIS 300 MG/3 ML VIAL 3ML medical supplies. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 23, 2022. This award is not associated with a set-aside program. AmerisourceBergen holds a...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the supply of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty medication. The $46,826.19 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency responsible for supplying medical commodities to military healthcare providers. The contract has an ultimate completion date of August 26, 2024. AmerisourceBergen, through its...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract provides for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product, with a ceiling value of $46,826.19 and an ultimate completion date of August 26, 2024. The contract is a Delivery Order under a Firm Fixed Price arrangement. This award is not associated with any set-aside program. AmerisourceBergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a specialty pharmaceutical product, with a ceiling value of $46,826.19. The contract has a firm fixed price pricing type and an ultimate completion date of October 16, 2024. This award is not associated with any set-aside program. Amerisourcebergen, a major supplier of...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at up to $93,628.70, is for the delivery of ULTOMIRIS 300 MG/3 ML VIAL 3ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has a completion date of July 2, 2024.
Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to...
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a firm fixed price delivery order valued at $46,814.35 to provide ULTOMIRIS 300 MG/3 ML VIAL 3ML pharmaceuticals. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ULTOMIRIS 1,100 MG/11 ML VIAL 11ML, a pharmaceutical product, to the U.S. Department of Defense (DoD) and its Medical Supply Chain agency. The contract, valued at $93,652.38, is a Firm Fixed Price Delivery Order with a completion date of July 17, 2024. This award is not associated with a set-aside program.
Amerisourcebergen, a major pharmaceutical distribution company, holds several...